CD274 and familial pancreatic carcinoma: With MEK inhibition and PD-1 blocking boosting TIL infiltration and increasing outcomes in pancreatic cancer, these results imply that PD-L1 expression and TIL presence may be biomarkers to predict response to radiation-immunotherapy combinations [96].